Merck (NYSE: MRK) will present multiple late-breaker data sets from its HIV treatment and prevention pipeline at the 26th International ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE